Loss of TTC17 promotes breast cancer metastasis through RAP1/CDC42 signaling and sensitizes it to rapamycin and paclitaxel.

Cell Biosci · 2023 · PMC9996991 · PMID 36895029

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an overall trendno p-value reported

Second, the quantitative statistical plots corresponding to immunohistochemical staining showed that the difference in TTC17 expression in mPT compared with non-mPT, although not reaching statistical significance, had a smaller mean value and showed an overall trend of reduced expression.

also in 4,871 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.